Trial Profile
Tinzaparin sodium for treatment of recurrent spontaneous abortion (miscarriage) in patients who negatively tested for antiphospholipid antibodies
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Feb 2013
Price :
$35
*
At a glance
- Drugs Tinzaparin sodium (Primary) ; Folic acid
- Indications Spontaneous abortion; Thrombosis
- Focus Therapeutic Use
- 01 Feb 2013 New trial record